retatrutide approval I've been asked a lot recently about Retatrutide, so I wanted to share some clear, factual information. is not licensed in the UK. It is still in clinical trials and cannot Retatrutide FDA Approval Status 2026:

These results position Retatrutide among the most promising investigational therapies in the field of weight management

Sources Wilding JPH et al

Common Questions About GLP-1 and Digestion Do GLP-1 medications affect digestive enzyme production

For a patient without coverage, or a cash-pay weight-management practice that wants an accessible first-line option, that price point is a genuine advantage part of why it remains the most commonly prescribed appetite suppressant

Quick Stats on Menopause Belly Fat 44 % average increase in visceral fat after menopause 4.9 higher risk of abdominal obesity post-menopause 65 % of U.S